Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
DaVita Inc.
DVA
$183.50
Name : DaVita Inc.
Sector : Healthcare
Industry: Medical Care Facilities
Mark. Cap: $11,542,150,144.00
EPSttm : 13.21
finviz dynamic chart for DVA
DaVita Inc.
$183.50
2.35%
$4.22
DVA — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

7.96

Margin Of Safety %

20

Put/Call OI Ratio

0.51

EPS Next Q Diff

-0.52

EPS Last/This Y

3.89

EPS This/Next Y

2.2

Price

179.28

Target Price

231.83

Analyst Recom

2.27

Performance Q

-1.33

Upside

62.4%

Beta

0.86

Ticker: DVA




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-12DVA181.80.500.9672059
2026-10-13DVA182.10.502.8772139
2026-10-14DVA180.730.511.2572706
2026-10-15DVA189.150.510.2872823
2026-10-16DVA187.260.500.0373326
2026-10-19DVA187.110.520.1663186
2026-10-20DVA175.220.521.6663361
2026-10-21DVA176.690.530.4864134
2026-10-22DVA186.270.530.2664575
2026-10-23DVA183.680.531.0964770
2026-10-26DVA184.110.530.0165133
2026-10-27DVA181.670.520.1466803
2026-10-28DVA184.060.510.5066909
2026-10-29DVA193.470.510.5466934
2026-10-30DVA186.850.511.0269888
2026-11-02DVA185.60.510.4070026
2026-11-03DVA182.180.510.7170119
2026-11-04DVA192.630.510.1669872
2026-11-05DVA194.760.520.0869303
2026-11-06DVA191.340.520.1269919
2026-11-09DVA185.540.511.1770496
2026-11-10DVA179.20.511.4970253
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-12DVA181.8042.4214.114.82
2026-10-13DVA182.3842.4204.314.82
2026-10-14DVA180.6242.4191.914.82
2026-10-15DVA189.0542.4238.414.82
2026-10-16DVA187.2542.4189.614.82
2026-10-19DVA187.1242.4198.914.82
2026-10-20DVA187.1242.4198.914.82
2026-10-21DVA175.0742.4135.014.82
2026-10-22DVA186.2942.4252.914.82
2026-10-23DVA183.6542.4186.014.82
2026-10-26DVA183.9642.4201.714.82
2026-10-27DVA181.7342.4187.314.82
2026-10-28DVA183.9842.4212.614.82
2026-10-29DVA193.3242.4251.514.79
2026-10-30DVA187.5042.4168.814.79
2026-11-02DVA185.7229.4141.014.82
2026-11-03DVA182.2024.2122.014.62
2026-11-04DVA192.6624.6208.014.68
2026-11-05DVA194.7024.6161.514.68
2026-11-06DVA191.3724.6132.314.68
2026-11-09DVA185.4524.6119.014.68
2026-11-10DVA179.2824.6116.614.67
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-12DVA-54.31-3.648.24
2026-10-13DVA-54.31-3.648.24
2026-10-14DVA-54.31-3.648.24
2026-10-15DVA-54.31-3.648.24
2026-10-16DVA-54.31-3.648.24
2026-10-19DVA-54.31-3.468.24
2026-10-20DVA-54.31-3.468.24
2026-10-21DVA-54.31-3.468.24
2026-10-22DVA-54.31-3.468.24
2026-10-23DVA-54.31-3.468.24
2026-10-26DVA-54.31-3.548.24
2026-10-27DVA-54.31-3.547.85
2026-10-28DVA-54.31-3.547.85
2026-10-29DVA-54.31-3.547.85
2026-10-30DVA-59.63-3.547.85
2026-11-02DVA-59.97-3.367.96
2026-11-03DVA-59.97-3.367.96
2026-11-05DVA-59.97-3.367.96
2026-11-06DVA-36.11-3.367.96
2026-11-09DVA-36.04-3.727.96
2026-11-10DVA-36.04-3.727.96
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

3.82

Avg. EPS Est. Current Quarter

4.24

Avg. EPS Est. Next Quarter

3.3

Insider Transactions

-36.04

Institutional Transactions

-3.72

Beta

0.86

Average Sales Estimate Current Quarter

3649

Average Sales Estimate Next Quarter

3524

Fair Value

215.47

Quality Score

67

Growth Score

84

Sentiment Score

67

Actual DrawDown %

27.6

Max Drawdown 5-Year %

-47

Target Price

231.83

P/E

13.54

Forward P/E

10.75

PEG

0.49

P/S

0.8

P/B

P/Free Cash Flow

8.7

EPS

13.22

Average EPS Est. Cur. Y​

14.67

EPS Next Y. (Est.)

16.87

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

6.32

Relative Volume

1.33

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.1

EBIT Estimation

116.6
◆ DVA Healthcare
$179.09
📉
Swing / Pullback
Buy the dip on strong trends
49 /100
WEAK
Trend
12/20
Pullback
11/25
Volume
0/15
Valuation
18/20
TP/AR
3/10
Options
5/10
RSI
44.6
Range 1M
28.4%
🚀
Momentum Growth
Ride accelerating trends
N/A
38 /100
WEAK
Momentum
4/25
Growth
18/30
Estimates
7/20
Inst/Vol
3/15
Options
6/10
EPS Yr
36.4%
EPS NY
13.3%
52W%
52.9%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +65.6% upside
Quality
7/30
Valuation
23/30
Growth
17/25
Stability
6/10
LT Trend
4/5
Upside
+65.6%
Quality
67
MoS
20%
DVA — P/E HistoricalMedical Care Facilities
DaVita Inc.
Sector: Healthcare
Industry: Medical Care Facilities
Employees: 78000
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
DVA

Latest News

—
Caricamento notizie per DVA…
stock quote shares DVA – DaVita Inc. Stock Price stock today
news today DVA – DaVita Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DVA – DaVita Inc. yahoo finance google finance
stock history DVA – DaVita Inc. invest stock market
stock prices DVA premarket after hours
ticker DVA fair value insiders trading